GB2012166A - Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts. - Google Patents

Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.

Info

Publication number
GB2012166A
GB2012166A GB7835598A GB7835598A GB2012166A GB 2012166 A GB2012166 A GB 2012166A GB 7835598 A GB7835598 A GB 7835598A GB 7835598 A GB7835598 A GB 7835598A GB 2012166 A GB2012166 A GB 2012166A
Authority
GB
United Kingdom
Prior art keywords
morpholinocarbonyloxymethyl
8beta
ergoline
bromo
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7835598A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siphar SA
Original Assignee
Siphar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar SA filed Critical Siphar SA
Publication of GB2012166A publication Critical patent/GB2012166A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Abstract

Compositions containing D-2- bromo-6-methyl-8beta-(morpholinocarbonyloxymethyl) ergoline as such or in the form of its salts in pharmaceutically acceptable formulations are used in the treatment of asthma.
GB7835598A 1978-01-17 1978-09-05 Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts. Withdrawn GB2012166A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH48478A CH632161A5 (en) 1978-01-17 1978-01-17 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ASTHMA.

Publications (1)

Publication Number Publication Date
GB2012166A true GB2012166A (en) 1979-07-25

Family

ID=4188059

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7835598A Withdrawn GB2012166A (en) 1978-01-17 1978-09-05 Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.

Country Status (5)

Country Link
JP (1) JPS54100396A (en)
BE (1) BE870414R (en)
CH (1) CH632161A5 (en)
FR (1) FR2414333A2 (en)
GB (1) GB2012166A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2185886A (en) * 1986-01-31 1987-08-05 Sandoz Ltd Immunosuppressant agents containing ergot derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH619709A5 (en) * 1975-03-14 1980-10-15 Siphar Sa Process for the preparation of carbamates of 2-halogenoergolines and 2-halogenoergolenes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2185886A (en) * 1986-01-31 1987-08-05 Sandoz Ltd Immunosuppressant agents containing ergot derivatives

Also Published As

Publication number Publication date
CH632161A5 (en) 1982-09-30
BE870414R (en) 1979-01-02
JPS54100396A (en) 1979-08-08
FR2414333A2 (en) 1979-08-10

Similar Documents

Publication Publication Date Title
NZ192196A (en) 1-phenyl-2-azolyl-ethanols pharmaceutical compositions
DE3370482D1 (en) Substituted 8-phenylxanthines
ZA832135B (en) Norscopine ethers,processes for their preparation and pharmaceutical compositions thereof
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
DE3063905D1 (en) Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
ZA824118B (en) Saturated aminocyclitol derivatives, their preparation and medicaments containing these compounds
PT71308A (en) Process for the preparation of new 3,4,5-trihidrocy-piperidine derivatives with pharmaceutical and/or veterinary effect
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
DE3060669D1 (en) Phenylalanyl-tryptophan derivatives, pharmaceutical compositions containing them, their preparation and use
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.
DE3062300D1 (en) Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters, their preparation and pharmaceutical compositions containing them
ZA796513B (en) Substituted 2-phenylamino-imidazolines-(2),having particular therapeutic properties,process for their preparation,and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)